Page last updated: 2024-08-17

carbostyril and fluorobenzenes

carbostyril has been researched along with fluorobenzenes in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basile, AS; Lippa, AS; Skolnick, P1
Andrews, J; Cheng, A; Custodio, JM; Hao, J; Kearney, BP; Lepist, EI; Ling, KH; Ramanathan, S; Ray, AS; Wang, H1
Futamura, T; Hashimoto, K; Ishima, T; Kikuchi, T; Ohgi, Y; Yoshimi, N1
Chen, ST; Ho, CT; Kuo, SC; Liu, LC; Way, TD; Wu, YC1

Reviews

1 review(s) available for carbostyril and fluorobenzenes

ArticleYear
Anxioselective anxiolytics: can less be more?
    European journal of pharmacology, 2004, Oct-01, Volume: 500, Issue:1-3

    Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepinones; Carbolines; Clinical Trials as Topic; Fluorobenzenes; GABA-A Receptor Agonists; Humans; Indoles; Pyrroles; Quinolones; Triazoles

2004

Trials

1 trial(s) available for carbostyril and fluorobenzenes

ArticleYear
Pharmacokinetics of cobicistat boosted-elvitegravir administered in combination with rosuvastatin.
    Journal of clinical pharmacology, 2014, Volume: 54, Issue:6

    Topics: Adult; Animals; Anti-HIV Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Carbamates; CHO Cells; Cobicistat; Cricetulus; Dogs; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver-Specific Organic Anion Transporter 1; Madin Darby Canine Kidney Cells; Male; Neoplasm Proteins; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Pyrimidines; Quinolones; Rosuvastatin Calcium; Solute Carrier Organic Anion Transporter Family Member 1B3; Sulfonamides; Thiazoles

2014

Other Studies

2 other study(ies) available for carbostyril and fluorobenzenes

ArticleYear
Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: a role for serotonin 5-HT1A and 5-HT2A receptors.
    European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:4

    Topics: Animals; Aripiprazole; Boron Compounds; Dose-Response Relationship, Drug; Drug Synergism; Fluorobenzenes; HSP90 Heat-Shock Proteins; Inositol 1,4,5-Trisphosphate Receptors; Macrocyclic Compounds; Nerve Growth Factor; Neurites; Oxazoles; PC12 Cells; Piperazines; Piperidines; Pyridines; Quinolones; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin Agents; Thiophenes

2015
2-Phenylnaphthyridin-4-one Derivative LYF-11 Inhibits Interleukin-6-mediated Epithelial-to-Mesenchymal Transition
    Anticancer research, 2018, Volume: 38, Issue:5

    Topics: Antineoplastic Agents; Breast Neoplasms; Epithelial-Mesenchymal Transition; Fluorobenzenes; Humans; Interleukin-6; Janus Kinase 2; MCF-7 Cells; Naphthyridines; Quinolones; Signal Transduction; STAT3 Transcription Factor

2018